cell therapy (Allelix)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namecell therapy (Allelix)
Drug Alias Nameglialines (Trophix)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsNerve DegenerationAlzheimer DiseaseParkinson Disease +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAllelix Neuroscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNerve DegenerationAlzheimer DiseaseParkinson Disease +[4

Other Information

ATC CodeN/A
Related LinksN/A